BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He XY, Liu BY, Peng Y, Zhuo RX, Cheng SX. Multifunctional Vector for Delivery of Genome Editing Plasmid Targeting β-Catenin to Remodulate Cancer Cell Properties. ACS Appl Mater Interfaces 2019;11:226-37. [PMID: 30540162 DOI: 10.1021/acsami.8b17481] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen G, Deng S, Zuo M, Wang J, Cheng D, Chen B. Non-viral CRISPR activation system targeting VEGF-A and TGF-β1 for enhanced osteogenesis of pre-osteoblasts implanted with dual-crosslinked hydrogel. Mater Today Bio 2022;16:100356. [PMID: 35898441 DOI: 10.1016/j.mtbio.2022.100356] [Reference Citation Analysis]
2 Caprifico AE, Foot PJS, Polycarpou E, Calabrese G. Advances in Chitosan-Based CRISPR/Cas9 Delivery Systems. Pharmaceutics 2022;14:1840. [DOI: 10.3390/pharmaceutics14091840] [Reference Citation Analysis]
3 Zhao B, Wang Z, Liang X, Wang X, Lin K, Yuan L, Jiang J, Xu C, Zhang D, Sun Y, Bian W. Inhibition of the postsynaptic density protein 95 on the protective effect of Ang-(1-7)-Mas on cerebral ischaemia injury. Stroke Vasc Neurol 2022:svn-2021-001396. [PMID: 35725243 DOI: 10.1136/svn-2021-001396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Vats S, Kumawat S, Brar J, Kaur S, Yadav K, Magar SG, Jadhav PV, Salvi P, Sonah H, Sharma S, Deshmukh R. Opportunity and challenges for nanotechnology application for genome editing in plants. Plant Nano Biology 2022;1:100001. [DOI: 10.1016/j.plana.2022.100001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Falato L, Vunk B, Langel Ü. CRISPR/Cas9 Plasmid Delivery Through the CPP: PepFect14. Methods Mol Biol 2022;2383:587-93. [PMID: 34766316 DOI: 10.1007/978-1-0716-1752-6_38] [Reference Citation Analysis]
6 Xu X, Liu C, Wang Y, Koivisto O, Zhou J, Shu Y, Zhang H. Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment. Adv Drug Deliv Rev 2021;176:113891. [PMID: 34324887 DOI: 10.1016/j.addr.2021.113891] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 22.0] [Reference Citation Analysis]
7 Zhao P, Wang Y, Sun W, Qi L, Hu L, Zhou T, Xing L, Cho K, Li C, Cho C, Jiang H. Recent Progress in Biomedical Applications of Chitosan Derivatives as Gene Carrier. Advances in Polymer Science 2021. [DOI: 10.1007/12_2021_106] [Reference Citation Analysis]
8 Tang H, Zhao X, Jiang X. Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing. Adv Drug Deliv Rev 2021;168:55-78. [PMID: 32147450 DOI: 10.1016/j.addr.2020.03.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 21.0] [Reference Citation Analysis]
9 Song X, Liu C, Wang N, Huang H, He S, Gong C, Wei Y. Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy. Adv Drug Deliv Rev 2021;168:158-80. [PMID: 32360576 DOI: 10.1016/j.addr.2020.04.010] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 41.0] [Reference Citation Analysis]
10 Kim D, Le QV, Wu Y, Park J, Oh YK. Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing. Pharmaceutics 2020;12:E1233. [PMID: 33353099 DOI: 10.3390/pharmaceutics12121233] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
11 Ren X, He X, Liu B, Xu C, Cheng S. Self-Assembled Plasmid Delivery System for PPM1D Knockout to Reverse Tumor Malignancy. ACS Appl Bio Mater 2020;3:7831-7839. [DOI: 10.1021/acsabm.0c01009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Xu X, Wan T, Xin H, Li D, Pan H, Wu J, Ping Y. Delivery of CRISPR/Cas9 for therapeutic genome editing. J Gene Med 2019;21:e3107. [PMID: 31237055 DOI: 10.1002/jgm.3107] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 33.5] [Reference Citation Analysis]
13 Lau CH, Tin C. The Synergy between CRISPR and Chemical Engineering. Curr Gene Ther 2019;19:147-71. [PMID: 31267870 DOI: 10.2174/1566523219666190701100556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Vaughan HJ, Green JJ, Tzeng SY. Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery. Adv Mater 2020;32:e1901081. [PMID: 31222852 DOI: 10.1002/adma.201901081] [Cited by in Crossref: 72] [Cited by in F6Publishing: 79] [Article Influence: 36.0] [Reference Citation Analysis]
15 He XY, Ren XH, Peng Y, Zhang JP, Ai SL, Liu BY, Xu C, Cheng SX. Aptamer/Peptide-Functionalized Genome-Editing System for Effective Immune Restoration through Reversal of PD-L1-Mediated Cancer Immunosuppression. Adv Mater 2020;32:e2000208. [PMID: 32147886 DOI: 10.1002/adma.202000208] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 28.0] [Reference Citation Analysis]
16 Wang J, Song J, Ji Z, Liu J, Guo X, Zhao Y, Yuan J. The preparation of calcium carbonate with different morphologies under the effect of alkanolamide 6502. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2020;588:124392. [DOI: 10.1016/j.colsurfa.2019.124392] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
17 Shim G, Kim D, Le Q, Byun J, Park J, Oh Y. Biomaterials for gene editing therapeutics. Biomaterials for Cancer Therapeutics 2020. [DOI: 10.1016/b978-0-08-102983-1.00008-9] [Reference Citation Analysis]
18 Liu B, He X, Xu C, Ren X, Zhuo R, Cheng S. Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing. ACS Appl Mater Interfaces 2019;11:23870-9. [DOI: 10.1021/acsami.9b05772] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
19 Lee M, Kim H. Therapeutic application of the CRISPR system: current issues and new prospects. Hum Genet 2019;138:563-90. [DOI: 10.1007/s00439-019-02028-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]